T-cell responses to HLA-A*0201 immunodominant peptides derived from α-fetoprotein in patients with hepatocellular cancerBUTTERFIELD, Lisa H; RIBAS, Antoni; ECONOMOU, James S et al.Clinical cancer research. 2003, Vol 9, Num 16, pp 5902-5908, issn 1078-0432, 7 p., 1Article

A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptidesBUTTERFIELD, Lisa H; RIBAS, Antoni; MCBRIDE, William H et al.Clinical cancer research. 2006, Vol 12, Num 9, pp 2817-2825, issn 1078-0432, 9 p.Article

Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206RIBAS, Antoni; CAMACHO, Luis H; SHARMA, Amarnath et al.Journal of clinical oncology. 2005, Vol 23, Num 35, pp 8968-8977, issn 0732-183X, 10 p.Article

Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapyRIBAS, Antoni; GLASPY, John A; AMARNANI, Saral N et al.Journal of immunotherapy (1997). 2004, Vol 27, Num 5, pp 354-367, issn 1524-9557, 14 p.Article

Surveillance of the Eye and Vision in Clinical Trials of CP-675,206 for Metastatic MelanomaSTRAATSMA, Bradley R; NUSINOWITZ, Steven; GOMEZ-NAVARRO, Jesus et al.American journal of ophthalmology. 2007, Vol 143, Num 6, pp 958-969, issn 0002-9394, 12 p.Article

Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assaysCOMIN-ANDUIX, Begona; GUALBERTO, Antonio; RIBAS, Antoni et al.Clinical cancer research. 2006, Vol 12, Num 1, pp 107-116, issn 1078-0432, 10 p.Article